참고문헌 (51)

1. Lyketsos CG, Lopez O, Jones B, Fitzpatrick AL, Breitner J, DeKosky S. Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: results from the cardiovascular health study. JAMA. 2002 Sep 25; 288(12):1475-83. 

   상세보기

2. Shin IS, Carter M, Masterman D, Fairbanks L, Cummings JL. Neuropsychiatric symptoms and quality of life in Alzheimer disease. Am J Geriatr Psychiatry Off J Am Assoc Geriatr Psychiatry. 2005 Jun;13(6):469-74. 

3. Kunik ME, Snow AL, Davila JA, McNeese T, Steele AB, Balasubramanyam V, et al. Consequences of aggressive behavior in patients with dementia. J Neuropsychiatry Clin Neurosci. 2010 Winter;22(1):40-7. 

   

4. McKeith I, Cummings J. Behavioural changes and psychological symptoms in dementia disorders. Lancet Neurol. 2005 Nov;4(11):735-42. 

   상세보기

5. Han YA, Hur HK. Formal Nursing Home Caregivers' Dementia Knowledge, Empathy, and Burden of Care from Behavioral and Psychological Symptoms of Dementia. J Korean Gerontol Nurs. 2020;22(3):216-25. 

   상세보기

6. Majer R, Adeyi O, Bagoly Z, Simon V, Csiba L, Kardos L, et al. Neuropsychiatric symptoms, quality of life and caregivers' burden in dementia. Open Med Wars Pol. 2020;15(1):905-14. 

7. Savva GM, Zaccai J, Matthews FE, Davidson JE, McKeith I, Brayne C. Prevalence, correlates and course of behavioural and psychological symptoms of dementia in the population. Br J Psychiatry J Ment Sci. 2009 Mar;194(3): 212-9. 

8. Lyketsos CG, Steinberg M, Tschanz JT, Norton MC, Steffens DC, Breitner JC. Mental and behavioral disturbances in dementia: findings from the Cache County Study on Memory in Aging. Am J Psychiatry. 2000 May; 157(5):708-14. 

   상세보기

9. Rabins PV, Blacker D, Rovner BW, Rummans T, Schneider LS, Tariot PN, et al. American Psychiatric Association practice guideline for the treatment of patients with Alzheimer's disease and other dementias. Second edition. Am J Psychiatry. 2007 Dec;164(12 Suppl):5-56. 

10. Lyketsos CG, Steele C, Galik E, Rosenblatt A, Steinberg M, Warren A, et al. Physical aggression in dementia patients and its relationship to depression. Am J Psychiatry. 1999 Jan;156(1):66-71. 

    상세보기

11. Shub D, Ball V, Abbas A-AA, Gottumukkala A, Kunik ME. The link between psychosis and aggression in persons with dementia: a systematic review. Psychiatr Q. 2010 Jun;81(2):97-110. 

    상세보기

12. Miyamoto Y, Tachimori H, Ito H. Formal caregiver burden in dementia: impact of behavioral and psychological symptoms of dementia and activities of daily living. Geriatr Nurs N Y N. 2010 Aug;31(4):246-53. 

13. Matsumoto N, Ikeda M, Fukuhara R, Shinagawa S, Ishikawa T, Mori T, et al. Caregiver burden associated with behavioral and psychological symptoms of dementia in elderly people in the local community. Dement Geriatr Cogn Disord. 2007;23(4):219-24. 

    상세보기

14. de Oliveira AM, Radanovic M, de Mello PCH, Buchain PC, Vizzotto ADB, Celestino DL, et al. Nonpharmacological Interventions to Reduce Behavioral and Psychological Symptoms of Dementia: A Systematic Review. BioMed Res Int. 2015;2015:218980. 

    상세보기

15. Azermai M, Petrovic M, Elseviers MM, Bourgeois J, Van Bortel LM, Vander Stichele RH. Systematic appraisal of dementia guidelines for the management of behavioural and psychological symptoms. Ageing Res Rev. 2012 Jan; 11(1):78-86. 

    상세보기

16. Watt JA, Gomes T, Bronskill SE, Huang A, Austin PC, Ho JM, et al. Comparative risk of harm associated with trazodone or atypical antipsychotic use in older adults with dementia: a retrospective cohort study. CMAJ Can Med Assoc J J Assoc Medicale Can. 2018 Nov 26;190(47): E1376-83. 

17. Kim Y, Cho SH. Danggui-Shaoyao-San for dementia: A PRISMA-compliant systematic review and meta-analysis. Med U S [Internet]. 2020;99(4). Available from: https://www.embase.com/search/results?subactionview-record&idL631132389&fromexport 

18. Kim TH, Kang JW. Herbal Medicine for Vascular Dementia: An Overview of Systematic Reviews. Curr Vasc Pharmacol. 2020;18(4):394-409. 

19. Lee MS, Shin BC, Ernst E. Acupuncture for Alzheimer's disease: a systematic review. Int J Clin Pract. 2009 Jun;63(6):874-9. 

    상세보기

20. Kwon C-Y, Lee B, Suh HW, Chung SY, Kim JW. Efficacy and Safety of Auricular Acupuncture for Cognitive Impairment and Dementia: A Systematic Review. Evid-Based Complement Altern Med ECAM. 2018;2018:3426078. 

21. Ahn HI, Hyun MK. Effectiveness of integrative medicine program for dementia prevention on cognitive function and depression of elderly in a public health center. Integr Med Res. 2019 Jun;8(2):133-7. 

22. Hyde AJ, May BH, Dong L, Feng M, Liu S, Guo X, et al. Herbal medicine for management of the behavioural and psychological symptoms of dementia (BPSD): A system - atic review and meta-analysis. J Psychopharmacol Oxf Engl. 2017 Feb;31(2):169-83. 

23. Mizukami K, Asada T, Kinoshita T, Tanaka K, Sonohara K, Nakai R, et al. A randomized cross-over study of a traditional Japanese medicine (kampo), yokukansan, in the treatment of the behavioural and psychological symptoms of dementia. Int J Neuropsychopharmacol. 2009;12(2):191-9. 

    상세보기

24. Matsuda Y, Kishi T, Shibayama H, Iwata N. Yokukansan in the treatment of behavioral and psychological symptoms of dementia: a systematic review and meta-analysis of randomized controlled trials. Hum Psychopharmacol. 2013 Jan;28(1):80-6. 

    상세보기

25. Mizukami K, Asada T, Kinoshita T, Tanaka K, Sonohara K, Nakai R, et al. A randomized cross-over study of a traditional Japanese medicine (kampo), yokukansan, in the treatment of the behavioural and psychological symptoms of dementia. Int J Neuropsychopharmacol. 2009 Mar;12(2):191-9. 

    상세보기

26. Shinno H, Inami Y, Inagaki T, Nakamura Y, Horiguchi J. Effect of Yi-Gan San on psychiatric symptoms and sleep structure at patients with behavioral and psychological symptoms of dementia. Prog Neuropsychopharmacol Biol Psychiatry. 2008;32(3):881-5. 

27. Okahara K, Ishida Y, Hayashi Y, Inoue T, Tsuruta K, Takeuchi K, et al. Effects of Yokukansan on behavioral and psychological symptoms of dementia in regular treatment for Alzheimer's disease. Prog Neuropsychopharmacol Biol Psychiatry. 2010 Apr 16;34(3):532-6. 

28. Nagata K, Yokoyama E, Yamazaki T, Takano D, Maeda T, Takahashi S, et al. Effects of yokukansan on behavioral and psychological symptoms of vascular dementia: an open-label trial. Phytomedicine Int J Phytother Phytopharm. 2012 Apr 15;19(6):524-8. 

29. Teranishi M, Kurita M, Nishino S, Takeyoshi K, Numata Y, Sato T, et al. Efficacy and tolerability of risperidone, yokukansan, and fluvoxamine for the treatment of behavioral and psychological symptoms of dementia: A blinded, randomized trial. J Clin Psychopharmacol. 2013;33(5):600-7. 

    상세보기

30. Furukawa K, Tomita N, Uematsu D, Okahara K, Shimada H, Ikeda M, et al. Randomized double-blind placebo-controlled multicenter trial of Yokukansan for neuropsychiatric symptoms in Alzheimer's disease. Geriatr Gerontol Int. 2017;17(2):211-8. 

    상세보기

31. Hayashi Y, Ishida Y, Inoue T, Udagawa M, Takeuchi K, Yoshimuta H, et al. Treatment of behavioral and psychological symptoms of Alzheimer-type dementia with Yokukansan in clinical practice. Prog Neuropsychopharmacol Biol Psychiatry. 2010;34(3):541-5. 

32. Hatano T, Hattori N, Kawanabe T, Terayama Y, Suzuki N, Iwasaki Y, et al. An exploratory study of the efficacy and safety of yokukansan for neuropsychiatric symptoms in patients with Parkinson's disease. J Neural Transm. 2014;121(3):275-81. 

    상세보기

33. Miyaoka T, Furuya M, Yasuda H, Hayashia M, Inagaki T, Horiguchi J. Yi-gan san for the treatment of borderline personality disorder: an open-label study. Prog Neuropsychopharmacol Biol Psychiatry. 2008;32(1):150-4. 

34. Wake R, Miyaoka T, Inagaki T, Furuya M, Ieda M, Liaury K, et al. Yokukansan (TJ-54) for irritability associated with pervasive developmental disorder in children and adolescents: a 12-week prospective, open-label study. J Child Adolesc Psychopharmacol. 2013 Jun;23(5):329-36. 

    상세보기

35. Miyaoka T, Wake R, Furuya M, Liaury K, Ieda M, Kawakami K, et al. Yokukansan (TJ-54) for treatment of pervasive developmental disorder not otherwise specified and Asperger's disorder: a 12-week prospective, open-label study. BMC Psychiatry. 2012 Nov 29;12:215. 

    상세보기

36. Tamano H, Kan F, Oku N, Takeda A. Ameliorative effect of Yokukansan on social isolation-induced aggressive behavior of zinc-deficient young mice. Brain Res Bull. 2010; 83(6):351-5. 

    상세보기

37. Katahira H, Sunagawa M, Watanabe D, Kanada Y, Katayama A, Yamauchi R, et al. Antistress effects of Kampo medicine "Yokukansan" via regulation of orexin secretion. Neuropsychiatr Dis Treat. 2017;13:863-72. 

    상세보기

38. Iba H, Watanabe T, Matsuzawa K, Saimiya M, Tanaka M, Nagao M, et al. Effect of Yokukansan and Yokukansanka-chimpihange on Aggressive Behavior, 5-HT Receptors and Arginine Vasopressin Expression in Social IsolationReared Mice. Biol Pharm Bull. 2019;42(12):2009-15. 

    상세보기

39. Kanno H , Sekiguchi K , Yam aguchi T, Teraw aki K , Yuzurihara M, Kase Y, et al. Effect of yokukansan, a traditional Japanese medicine, on social and aggressive behaviour of para-chloroamphetamine-injected rats. J Pharm Pharmacol. 2009;61(9):1249-56. 

    상세보기

40. Sekiguchi K, Imamura S, Yamaguchi T, Tabuchi M, Kanno H, Terawaki K, et al. Effects of yokukansan and donepezil on learning disturbance and aggressiveness induced by intracerebroventricular injection of amyloid β protein in mice. Phytother Res PTR. 2011 Apr;25(4):501-7. 

41. Sekiguchi K, Yamaguchi T, Tabuchi M, Ikarashi Y, Kase Y. Effects of yokukansan, a traditional Japanese medicine, on aggressiveness induced by intracerebroventricular injection of amyloid β protein into mice. Phytother Res. 2009;23(8):1175-81. 

    상세보기

42. Ikarashi Y, Iizuka S, Imamura S, Yamaguchi T, Sekiguchi K, Kanno H, et al. Effects of yokukansan, a traditional Japanese medicine, on memory disturbance and behavioral and psychological symptoms of dementia in thiamine-deficient rats. Biol Pharm Bull. 2009 Oct;32(10):1701-9. 

    상세보기

43. Iizuka S, Kawakami Z, Imamura S, Yamaguchi T, Sekiguchi K, Kanno H, et al. Electron-microscopic examination of effects of yokukansan, a traditional Japanese medicine, on degeneration of cerebral cells in thiamine-deficient rats. Neuropathol Off J Jpn Soc Neuropathol. 2010 Oct;30(5):524-36. 

44. Nishi A, Yamaguchi T, Sekiguchi K, Imamura S, Tabuchi M, Kanno H, et al. Geissoschizine methyl ether, an alkaloid in Uncaria hook, is a potent serotonin1A receptor agonist and candidate for amelioration of aggressiveness and sociality by yokukansan. Neuroscience. 2012;207 ((Nishi A., nishi_akinori@mail.tsumura.co.jp; Yamaguchi T.; Sekiguchi K.; Imamura S.; Tabuchi M.; Kanno H.; Ikarashi Y.; Kase Y.) Tsumura Research Laboratories, Tsumura and Co., 3586 Yoshiwara, Ami-machi, Inashikigun, Ibaraki 300-1192, Japan):124-36. 

    상세보기

45. Tamano H, Yusuke E, Ide K, Takeda A. Influences of yokukansankachimpihange on aggressive behavior of zincdeficient mice and actions of the ingredients on excessive neural exocytosis in the hippocampus of zinc-deficient rats. Exp Anim. 2016 Nov 1;65(4):353-61. 

    상세보기

46. Tahara E, Wu W, Satoh T, Yamada T, Kurosaki I, Nagai H, et al. Psychosocial stress enhances IgE-mediated triphasic cutaneous reaction in mice: Antagonism by Yokukansan (a kampo medicine) and diazepam. Allergol Int. 2001;50(3):211-21. 

    상세보기

47. Takeda A, Iwaki H, Ide K, Tamano H, Oku N. Therapeutic effect of Yokukansan on social isolation-induced aggressive behavior of zinc-deficient and pair-fed mice. Brain Res Bull. 2012;87(6):551-5. 

    상세보기

48. Tabuchi M, Mizuno K, Mizoguchi K, Hattori T, Kase Y. Yokukansan and yokukansankachimpihange ameliorate aggressive behaviors in rats with cholinergic degeneration in the nucleus basalis of meynert. Front Pharmacol [Internet]. 2017;8(APR). Available from: https://www.embase.com/search/results?subactionview-record&idL615893475&fromexport 

49. Uchida N, Egashira N, Iwasaki K, Ishibashi A, Tashiro R, Nogami A, et al. Yokukansan inhibits social isolation-induced aggression and methamphetamine-induced hyperlocomotion in rodents. Biol Pharm Bull. 2009 Mar;32(3):372-5. 

    상세보기

50. Fujiwara H, Takayama S, Iwasaki K, Tabuchi M, Yamaguchi T, Sekiguchi K, et al. Yokukansan, a traditional Japanese medicine, ameliorates memory disturbance and abnormal social interaction with anti-aggregation effect of cerebral amyloid β proteins in amyloid precursor protein transgenic mice. Neuroscience. 2011;180(2011):305-13. 

51. Mizoguchi K, Ikarashi Y. Cellular Pharmacological Effects of the Traditional Japanese Kampo Medicine Yokukansan on Brain Cells. Front Pharmacol. 2017;8:655. 

    상세보기